Marc E. Agronin, M.D.

Vice President, Behavioral Health and Clinical Research, Miami Jewish Health Systems

“In the next five years, we should have a clearer verdict on whether immunotherapy for Alzheimer’s disease really works when applied at early stages.”

Robin Wolz, M.D.

SVP, Research and Development, IXICO

“Currently, no drug treatments exist that slow AD progression, however, diet and other lifestyle choices have been shown to extend the period of independent living for AD sufferers.”

Emiliano Santarnecchi, Ph.D.

Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Cognitive Neurology, Beth Israel Deaconess Medical Center

“Thanks to emerging technologies, the landscape of Alzheimer’s research and care is rapidly changing.”